Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ginger: A Complementary Approach for Management of Cardiovascular Diseases Publisher Pubmed



Roudsari NM1 ; Lashgari NA1 ; Momtaz S2, 3, 4 ; Roufogalis B5, 6 ; Abdolghaffari AH1, 2, 3, 4 ; Sahebkar A7, 8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  2. 2. Medicinal Plants Research Center, Institute of Medicinal Plants, Academic Center for Education, Culture and Research, Tehran, Iran
  3. 3. Toxicology and Disease Group, Pharmaceutical Sciences Research Center, Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Gastrointestinal Pharmacology Interest Group, Universal Scientific Education and Research Network, Tehran, Iran
  5. 5. Discipline of Pharmacology, School of Medical Sciences, University of Sydney, Sydney, Australia
  6. 6. National Institute of Complementary Medicine, Western Sydney University, Westmead, Australia
  7. 7. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  9. 9. School of Medicine, The University of Western Australia, Perth, Australia

Source: BioFactors Published:2021


Abstract

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Inflammation and oxidative stress play critical roles in progression of various types of CVD. Broad pharmacological properties of ginger (the rhizome of Zingiber officinale) and its bioactive components have been reported, suggesting that they can be a therapeutic choice for clinical use. Consistent with its rich phenolic content, the anti-inflammatory and antioxidant properties of ginger have been confirmed in many studies. Ginger modifies many cellular processes and in particular was shown to have potent inhibitory effects against nuclear factor kappa B (NF-κB); signal transducer and activator of transcription; NOD-, LRR-, and pyrin domain-containing proteins; toll-like receptors; mitogen-activated protein kinase; and mammalian target of rapamycin signaling pathways. Ginger also blocks pro-inflammatory cytokines and the activation of the immune system. Ginger suppresses the activity of oxidative molecules such as reactive oxygen species, inducible nitric oxide synthase, superoxide dismutase, glutathione, heme oxygenase, and GSH-Px. In this report, we summarize the biochemical pathologies underpinning a variety of CVDs and the effects of ginger and its bioactive components, including 6-shogaol, 6-gingerol, and 10-dehydrogingerdione. The properties of ginger and its phenolic components, mechanism of action, biological functions, side effects, and methods for enhanced cell delivery are also discussed. Together with preclinical and clinical studies, the positive biological effects of ginger and its bioactive components in CVD support the undertaking of further in vivo and especially clinical studies. © 2021 International Union of Biochemistry and Molecular Biology.
Other Related Docs
12. Anti-Atherosclerotic Effects of Spice-Derived Phytochemicals, Current Medicinal Chemistry (2021)
14. Therapeutic Approaches for Cholestatic Liver Diseases: The Role of Nitric Oxide Pathway, Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
24. Harnessing Polyphenol Power by Targeting Enos for Vascular Diseases, Critical Reviews in Food Science and Nutrition (2023)
25. Analysis of Other Phenolics (Capsaicin, Gingerol, and Alkylresorcinols), Recent Advances in Natural Products Analysis (2020)